Not On Dialysis
Herpes zoster (shingles)
- CrCl 30-49: 1 g PO q12h
- CrCl 10-29: 1 g PO q24h
- CrCl <10: 500 mg PO q24h
Herpes labialis
- CrCl 30-49: 1 g PO q12h x 2 doses
- CrCl 10-29: 500 mg PO q12h x 2 doses
- CrCl <10: 500 mg PO as a single dose
Primary genital herpes
- CrCl 30-49: 1 g PO q12h
- CrCl 10-29: 1 g PO q24h
- CrCl <10: 500 mg PO q24h
Recurrent genital herpes
- CrCl 30-49: 500 mg PO q12h x 3 days OR 1 g PO q24h x 5 days
- CrCl <30: 500 mg PO q24h
Herpes simplex/Varicella zoster treatment in oncology patients
- CrCl 30-49: 1 g PO q12h
- CrCl 10-29: 1 g PO q24h
- CrCl <10: 500 mg PO q24h
Herpes simplex/Varicella zoster prophylaxis in oncology patients
- CrCl 30-49: 500 mg PO q8-12h
- CrCl 10-29: 500 mg PO q12h
- CrCl <10: 500 mg PO q24h
Intermittent Hemodialysis
HSV: 500 mg PO daily
VZV: 1 g PO daily
Give after dialysis on dialysis days
Intermittent Hemodialysis (HD), Peritoneal Dialysis
Dose for CrCl less than 10 mL/min
Give dose after dialysis session for HD patients